Sinphar Pharmaceutical Co Ltd (1734) — Capital Reinvestment Ratio
Sinphar Pharmaceutical Co Ltd (1734) has a Capital Reinvestment Ratio of 0.87x as of March 2026, meaning it reinvests 1% of its operating cash flow (NT$116.42 Million) in capital expenditures (NT$101.07 Million). Check Sinphar Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sinphar Pharmaceutical Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Sinphar Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Sinphar Pharmaceutical Co Ltd.
Annual Capital Reinvestment Ratio for Sinphar Pharmaceutical Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Sinphar Pharmaceutical Co Ltd from 2003 to 2025. See 1734 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | NT$584.66 Million | NT$200.94 Million | ▼ -20.5% |
| 2024 | 0.43x | NT$593.51 Million | NT$256.71 Million | ▼ -57.4% |
| 2023 | 1.02x | NT$296.37 Million | NT$300.94 Million | ▲ +181.4% |
| 2022 | 0.36x | NT$425.30 Million | NT$153.44 Million | ▼ -69.7% |
| 2021 | 1.19x | NT$135.54 Million | NT$161.44 Million | ▲ +10.5% |
| 2020 | 1.08x | NT$146.39 Million | NT$157.77 Million | ▼ -66.5% |
| 2018 | 3.22x | NT$79.50 Million | NT$255.69 Million | ▲ +313.5% |
| 2017 | 0.78x | NT$219.87 Million | NT$171.00 Million | ▼ -69.8% |
| 2016 | 2.58x | NT$87.18 Million | NT$224.85 Million | ▲ +75.6% |
| 2015 | 1.47x | NT$280.53 Million | NT$412.04 Million | ▼ -25.8% |
| 2014 | 1.98x | NT$148.58 Million | NT$294.29 Million | ▼ -1.6% |
| 2013 | 2.01x | NT$297.09 Million | NT$598.16 Million | ▼ -11.8% |
| 2012 | 2.28x | NT$164.45 Million | NT$375.19 Million | ▲ +42.3% |
| 2011 | 1.60x | NT$225.58 Million | NT$361.69 Million | ▲ +43.2% |
| 2010 | 1.12x | NT$261.49 Million | NT$292.75 Million | ▲ +57.9% |
| 2009 | 0.71x | NT$309.94 Million | NT$219.71 Million | ▼ -17.6% |
| 2008 | 0.86x | NT$271.01 Million | NT$233.25 Million | ▼ -63.7% |
| 2007 | 2.37x | NT$174.85 Million | NT$414.90 Million | ▲ +58.5% |
| 2006 | 1.50x | NT$166.57 Million | NT$249.44 Million | ▼ -3.1% |
| 2005 | 1.55x | NT$122.09 Million | NT$188.76 Million | ▲ +68.1% |
| 2004 | 0.92x | NT$174.81 Million | NT$160.79 Million | ▼ -57.3% |
| 2003 | 2.16x | NT$120.84 Million | NT$260.50 Million | — |